MELISSA WARNER: Open Payments
NPI 1457069965 · ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,398 in 137 payments from 19 companies in 2025. Trend: 2023 $2,990 · 2024 $3,777 · 2025 $3,398
Food & beverage: $3,168Education: $231
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $772 |
| Incyte Corporation | 16 | $457 |
| ABBVIE INC. | 14 | $280 |
| UCB, Inc. | 12 | $276 |
| Lilly USA, LLC | 12 | $264 |
| E.R. Squibb & Sons, L.L.C. | 9 | $205 |
| Amgen Inc. | 9 | $178 |
| Novartis Pharmaceuticals Corporation | 6 | $154 |
| Regeneron Healthcare Solutions, Inc. | 4 | $152 |
| Galderma Laboratories, L.P. | 6 | $105 |
Products named: TREMFYA, OPZELURA, DUPIXENT, Bimzelx, TALTZ, RINVOQ, Sotyktu, OTEZLA.
Industry payments across MA — which companies pay providers there.
